» Articles » PMID: 33235324

Radiomic Prediction of Radiation Pneumonitis on Pretreatment Planning Computed Tomography Images Prior to Lung Cancer Stereotactic Body Radiation Therapy

Overview
Journal Sci Rep
Specialty Science
Date 2020 Nov 25
PMID 33235324
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

This study developed a radiomics-based predictive model for radiation-induced pneumonitis (RP) after lung cancer stereotactic body radiation therapy (SBRT) on pretreatment planning computed tomography (CT) images. For the RP prediction models, 275 non-small-cell lung cancer patients consisted of 245 training (22 with grade ≥ 2 RP) and 30 test cases (8 with grade ≥ 2 RP) were selected. A total of 486 radiomic features were calculated to quantify the RP texture patterns reflecting radiation-induced tissue reaction within lung volumes irradiated with more than x Gy, which were defined as LVx. Ten subsets consisting of all 22 RP cases and 22 or 23 randomly selected non-RP cases were created from the imbalanced dataset of 245 training patients. For each subset, signatures were constructed, and predictive models were built using the least absolute shrinkage and selection operator logistic regression. An ensemble averaging model was built by averaging the RP probabilities of the 10 models. The best model areas under the receiver operating characteristic curves (AUCs) calculated on the training and test cohort for LV5 were 0.871 and 0.756, respectively. The radiomic features calculated on pretreatment planning CT images could be predictive imaging biomarkers for RP after lung cancer SBRT.

Citing Articles

Radiation Pneumonitis Prediction Using Dual-Modal Data Fusion Based on Med3D Transfer Network.

Tang J, Wang H, Wu D, Kong Y, Huang J, Han S J Imaging Inform Med. 2024; .

PMID: 39633211 DOI: 10.1007/s10278-024-01339-9.


Predicting radiation pneumonitis in lung cancer using machine learning and multimodal features: a systematic review and meta-analysis of diagnostic accuracy.

Chen Z, Yi G, Li X, Yi B, Bao X, Zhang Y BMC Cancer. 2024; 24(1):1355.

PMID: 39501204 PMC: 11539622. DOI: 10.1186/s12885-024-13098-5.


Deep-Learning Model Prediction of Radiation Pneumonitis Using Pretreatment Chest Computed Tomography and Clinical Factors.

Lee J, Kang M, Park J, Lee S, Kim J, Park S Technol Cancer Res Treat. 2024; 23:15330338241254060.

PMID: 38752262 PMC: 11102700. DOI: 10.1177/15330338241254060.


Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study.

Cheung B Radiat Oncol J. 2024; 42(1):4-16.

PMID: 38549380 PMC: 10982060. DOI: 10.3857/roj.2023.00612.


Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition.

Kraus K, Oreshko M, Bernhardt D, Combs S, Peeken J Front Oncol. 2023; 13:1124592.

PMID: 37007119 PMC: 10050584. DOI: 10.3389/fonc.2023.1124592.


References
1.
GRAHAM M, Purdy J, Emami B, Harms W, Bosch W, Lockett M . Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999; 45(2):323-9. DOI: 10.1016/s0360-3016(99)00183-2. View

2.
Luna J, Chao H, Diffenderfer E, Valdes G, Chinniah C, Ma G . Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning. Radiother Oncol. 2019; 133:106-112. DOI: 10.1016/j.radonc.2019.01.003. View

3.
van der Ploeg T, Steyerberg E . Feature selection and validated predictive performance in the domain of Legionella pneumophila: a comparative study. BMC Res Notes. 2016; 9:147. PMC: 4782323. DOI: 10.1186/s13104-016-1945-2. View

4.
Yamashita H, Kobayashi-Shibata S, Terahara A, Okuma K, Haga A, Wakui R . Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol. 2010; 5:32. PMC: 2876174. DOI: 10.1186/1748-717X-5-32. View

5.
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K . Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys. 2010; 81(5):1352-8. DOI: 10.1016/j.ijrobp.2009.07.1751. View